Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.

Nanotechnology has become a key word of public interest, since people realized the social and economic power of nanotechnology development. Nanotechnology has already become part of our daily life, and it will have an as yet unknown technological impact because it concerns all aspects of human life from novel building materials to electronics, cosmetics, pharmaceutics, and medicine.1 In recent years, engineered nanoparticles started to become the most important components in nanotechnology. The InternationalOrganization for Standardization (ISO) has provided specific definitions in their recent document entitled “Nanotechnologies—Terminology and definitions for nanoobjects—Nanoparticle, nanofibre and nanoplate”. As the basis of this review, the following definitions for a nanoparticle (NP) and a nano-object will be used.

[1]  Michael Aschner,et al.  Effects of Nanoparticles on the Adhesion and Cell Viability on Astrocytes , 2007, Biological Trace Element Research.

[2]  Morteza Mahmoudi,et al.  Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.

[3]  L. Juillerat-Jeanneret,et al.  Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. , 2005, Biomaterials.

[4]  P Stroeve,et al.  Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.

[5]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[6]  H. Karlsson,et al.  Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. , 2008, Chemical research in toxicology.

[7]  Zhenghe Xu,et al.  Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. , 2008, International journal of pharmaceutics.

[8]  Peixuan Guo,et al.  Engineering RNA for Targeted siRNA Delivery and Medical Application , 2010, Advanced Drug Delivery Reviews.

[9]  A. Nel,et al.  Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. , 2002, Environmental health perspectives.

[10]  Christian Plank,et al.  Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.

[11]  Heather Kalish,et al.  Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. , 2003, Radiology.

[12]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[13]  A. Curtis,et al.  Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.

[14]  C. Ménager,et al.  Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles. , 2006, Journal of periodontology.

[15]  Morteza Mahmoudi,et al.  A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[16]  B. Rutt,et al.  Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. , 2008, Bioconjugate chemistry.

[17]  Morteza Mahmoudi,et al.  Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.

[18]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[19]  Abbas S. Milani,et al.  Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review , 2010 .

[20]  H. Vali,et al.  Cytotoxicity and Cell Cycle Effects of Bare and Poly(vinyl alcohol)‐Coated Iron Oxide Nanoparticles in Mouse Fibroblasts , 2009 .

[21]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[22]  M. Bock,et al.  Physical and Biological Characterization of Superparamagnetic Iron Oxide- and Ultrasmall Superparamagnetic Iron Oxide-Labeled Cells: A Comparison , 2005, Investigative radiology.

[23]  S E Seltzer,et al.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. , 1995, Radiology.

[24]  L. Murr,et al.  Cytotoxic effects of aggregated nanomaterials. , 2007, Acta biomaterialia.

[25]  Sangjin Park,et al.  Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. , 2008, Angewandte Chemie.

[26]  Beat Ernst,et al.  Drug discovery today. , 2003, Current topics in medicinal chemistry.

[27]  H. Byrne,et al.  Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity , 2007 .

[28]  R. Müller,et al.  Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles , 1996 .

[29]  Bernhard Gleich,et al.  Targeted delivery of magnetic aerosol droplets to the lung , 2007, Nature Nanotechnology.

[30]  O. Yurchenko,et al.  Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles. , 2010, Experimental oncology.

[31]  Jeremy N Skepper,et al.  Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. , 2007, Biomaterials.

[32]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[33]  David Heber,et al.  Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols , 2010, PloS one.

[34]  Xiaohua Huang,et al.  Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. , 2008, Accounts of chemical research.

[35]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[36]  R Weissleder,et al.  Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[37]  H. Hofmann,et al.  Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .

[38]  D. Tsai,et al.  Investigation of the Growth Mechanism of Iron Oxide Nanoparticles via a Seed-Mediated Method and Its Cytotoxicity Studies , 2008 .

[39]  Rebekah Drezek,et al.  In vivo biodistribution of nanoparticles. , 2011, Nanomedicine.

[40]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[41]  J. Gilman,et al.  Nanotechnology , 2001 .

[42]  M. Sahraian,et al.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. , 2011, ACS chemical neuroscience.

[43]  R. Misra,et al.  Biomaterials , 2008 .

[44]  Doris A Taylor,et al.  Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.

[45]  A. Curtis,et al.  Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis , 2003, IEEE Transactions on NanoBioscience.

[46]  Robert N Grass,et al.  Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. , 2005, Environmental science & technology.

[47]  Yu Zhang,et al.  Fluorescence Modified Chitosan-Coated Magnetic Nanoparticles for High-Efficient Cellular Imaging , 2009, Nanoscale research letters.

[48]  Martin J. D. Clift,et al.  Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative , 2010, Archives of Toxicology.

[49]  David B Warheit,et al.  Rationale of genotoxicity testing of nanomaterials: Regulatory requirements and appropriateness of available OECD test guidelines , 2010, Nanotoxicology.

[50]  Dar-Bin Shieh,et al.  Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications. , 2005, Biomaterials.

[51]  A. Curtis,et al.  Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. , 2003, Biomaterials.

[52]  Sungho Jin,et al.  Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. , 2007, Biomaterials.

[53]  J. Gearhart,et al.  In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[54]  Steffen Loft,et al.  Oxidative stress-induced DNA damage by particulate air pollution. , 2005, Mutation research.

[55]  A. Shiras,et al.  Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. , 2008, Chemistry.

[56]  K. Neoh,et al.  Cellular response to magnetic nanoparticles "PEGylated" via surface-initiated atom transfer radical polymerization. , 2006, Biomacromolecules.

[57]  M. Kadiiska,et al.  Synergistic production of lung free radicals by diesel exhaust particles and endotoxin. , 2005, American journal of respiratory and critical care medicine.

[58]  R. Franke,et al.  Inside Cover: A General and Efficient Iridium‐Catalyzed Hydroformylation of Olefins (Angew. Chem. Int. Ed. 1/2011) , 2011 .

[59]  Jinming Gao,et al.  MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. , 2009, Biomaterials.

[60]  P. Morais,et al.  In vitro biological activities of anionic gamma-Fe2O3 nanoparticles on human melanoma cells. , 2008, Journal of nanoscience and nanotechnology.

[61]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[62]  Tilman Grune,et al.  Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. , 2004, Free radical biology & medicine.

[63]  Alke Petri-Fink,et al.  Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[64]  Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems , 2009, Cancer Gene Therapy.

[65]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[66]  Do Kyung Kim,et al.  Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. , 2006, Journal of the American Chemical Society.

[67]  T. Waseem,et al.  Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes , 2008, Brain Research.

[68]  Elizabeth C. Theil,et al.  Ferritins: iron/oxygen biominerals in protein nanocages , 2006, JBIC Journal of Biological Inorganic Chemistry.

[69]  Changman Kim,et al.  Protective effect of maghemite nanoparticles on ultraviolet-induced photo-damage in human skin fibroblasts , 2007, Nanotechnology.

[70]  A. Dinischiotu,et al.  Depletion of intracellular glutathione and increased lipid peroxidation mediate cytotoxicity of hematite nanoparticles in MRC-5 cells. , 2010, Acta biochimica Polonica.

[71]  M. Mahmoudi,et al.  Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications , 2010 .

[72]  D. Français,et al.  Federal Office of Public Health FOPH , 2013 .

[73]  Karthikeyan Subramani,et al.  Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.

[74]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[75]  Andrew McCaskie,et al.  Nanomedicine , 2005, BMJ.

[76]  S. H. Lee,et al.  In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines , 2010, Bioprocess and biosystems engineering.

[77]  Agnes B Kane,et al.  Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. , 2008, Small.

[78]  M. Mahmoudi,et al.  Cytotoxicity of Uncoated and Polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles , 2009 .

[79]  S. Puntarulo Iron, oxidative stress and human health. , 2005, Molecular aspects of medicine.

[80]  D. Huhn,et al.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.

[81]  Andrew D Maynard,et al.  Nanotechnology: the next big thing, or much ado about nothing? , 2007, The Annals of occupational hygiene.

[82]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[83]  Andras Lakatos,et al.  Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS , 2004, The Journal of Neuroscience.

[84]  P. Borm,et al.  Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. , 2004, Mutation research.

[85]  F. Franconi,et al.  Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: In vitro characterization and migration potential in rat brain , 2009, Brain Research.

[86]  J. M. de la Fuente,et al.  Cell Response to Magnetic Glyconanoparticles: Does the Carbohydrate Matter? , 2007, IEEE Transactions on NanoBioscience.

[87]  Morteza Mahmoudi,et al.  An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure , 2009, Nanotechnology.

[88]  R. Weissleder,et al.  Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages , 1997, Journal of magnetic resonance imaging : JMRI.

[89]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[90]  Hongshi Yu,et al.  ADME-Tox in drug discovery: integration of experimental and computational technologies. , 2003, Drug discovery today.

[91]  S. Ammar,et al.  Evaluation of iron oxide nanoparticle biocompatibility , 2011, International journal of nanomedicine.

[92]  W. Parak,et al.  One example on how colloidal nano- and microparticles could contribute to medicine. , 2009, Nanomedicine.

[93]  M. Sastry,et al.  Gold nanoparticles as carriers for efficient transmucosal insulin delivery. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[94]  F. Ris,et al.  Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[95]  Joseph A Frank,et al.  In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy , 2008, Stem cells.

[96]  S. Shamim,et al.  Neurosurgery , 1943 .

[97]  Peter Wick,et al.  The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction , 2007 .

[98]  Mark R Wiesner,et al.  In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: A physicochemical and cyto-genotoxical study. , 2006, Environmental science & technology.

[99]  Jae-Bong Park,et al.  Phagocytosis induces superoxide formation and apoptosis in macrophages , 2003, Experimental & Molecular Medicine.

[100]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[101]  W. Hörl,et al.  Iron and infection. , 1999, Kidney international. Supplement.

[102]  Martin Bendszus,et al.  Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging , 2006, Journal of Neuroimmunology.

[103]  Eun-Mi Kim,et al.  Synthesis and characterization of iron oxide nanoparticles decorated with carboxymethyl curdlan , 2009 .

[104]  Lawrence E Murr,et al.  Comparative in vitro cytotoxicity assessment of some manufacturednanoparticulate materials characterized by transmissionelectron microscopy , 2005 .

[105]  E. Ogier-Denis,et al.  Diesel exhaust particles induce matrix metalloprotease-1 in human lung epithelial cells via a NADP(H) oxidase/NOX4 redox-dependent mechanism. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[106]  Sizhong Li,et al.  Carbon foams with high compressive strength derived from mesophase pitch treated by toluene extraction , 2007 .

[107]  T. Ihalainen,et al.  Magnetic resonance imaging of viral particle biodistribution in vivo , 2006, Gene Therapy.

[108]  G. Marchal,et al.  Experimental study of the pharmacokinetics and dose response of ferrite particles used as a contrast agent in MRI of the normal liver of the rabbit. , 1989, Investigative radiology.

[109]  Isabelle Raynal,et al.  Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.

[110]  Sabino Veintemillas-Verdaguer,et al.  The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells , 2009, Nanotechnology.

[111]  Gary Friedman,et al.  Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[113]  D. Leslie-Pelecky,et al.  Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. , 2008, Molecular pharmaceutics.

[114]  Sabrina S Wilson Radiology , 1938, Glasgow Medical Journal.

[115]  Feng Gao,et al.  Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells , 2008, International journal of nanomedicine.

[116]  Martyn T. Smith,et al.  The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. , 1996, Environmental health perspectives.

[117]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[118]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[119]  M. Mahmoudi,et al.  Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery , 2009 .

[120]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[121]  Thommey P. Thomas,et al.  Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. , 2007, Physical chemistry chemical physics : PCCP.

[122]  J. Gillard,et al.  Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. , 2008, Biomaterials.

[123]  Hon-Man Liu,et al.  Macrophage physiological function after superparamagnetic iron oxide labeling , 2008, NMR in biomedicine.

[124]  R. Ivkov,et al.  NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. , 2008, Bioconjugate chemistry.

[125]  Gary Friedman,et al.  High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents , 2008, Proceedings of the National Academy of Sciences.

[126]  H. Jeng,et al.  Toxicity of Metal Oxide Nanoparticles in Mammalian Cells , 2006, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[127]  Maria Jose Morilla,et al.  Nanotechnological approaches against Chagas disease. , 2010, Advanced drug delivery reviews.

[128]  Manuel Arruebo,et al.  Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. , 2008, Small.

[129]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[130]  Ajay Kumar Gupta,et al.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. , 2007, Nanomedicine.

[131]  Lang Tran,et al.  Safe handling of nanotechnology , 2006, Nature.

[132]  Paula M Jacobs,et al.  Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.

[133]  E. Syková,et al.  Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. , 2009, Bioconjugate chemistry.

[134]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[135]  Jun-Sung Kim,et al.  Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells , 2006, Journal of veterinary science.

[136]  A. Curtis,et al.  Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. , 2004, Biomaterials.

[137]  M Laird Forrest,et al.  Clinical toxicities of nanocarrier systems. , 2008, Advanced drug delivery reviews.

[138]  Robert Langer,et al.  Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy , 2011 .

[139]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[140]  F. Gao,et al.  Novel nanocomposite of nano fe(3)o(4) and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[141]  Morteza Mahmoudi,et al.  Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. , 2011, ACS nano.

[142]  K. Donaldson,et al.  Nuclear Factor Kappa-B Activation by Particles and Fibers , 2000, Inhalation toxicology.

[143]  Abbas S. Milani,et al.  Multiphysics Flow Modeling and in Vitro Toxicity of Iron Oxide Nanoparticles Coated with Poly(vinyl alcohol) , 2009 .

[144]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[145]  E. Niki,et al.  Ultrafine NiO particles induce cytotoxicity in vitro by cellular uptake and subsequent Ni(II) release. , 2009, Chemical research in toxicology.

[146]  T. Rindzevicius,et al.  Surface-Based Gold-Nanoparticle Sensor for Specific and Quantitative DNA Hybridization Detection , 2003 .

[147]  A. Dinda,et al.  Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress , 2010, International journal of nanomedicine.

[148]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[149]  Hossein Mozdarani,et al.  Study of apoptosis in labeled mesenchymal stem cells with superparamagnetic iron oxide using neutral comet assay. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[150]  O. Ohneda J Vet Sci , 2013 .

[151]  R. Weissleder,et al.  Delivery of virus-sized iron oxide particles to rodent CNS neurons. , 1994, Neurosurgery.

[152]  Youjia Cao,et al.  Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids. , 2007, Journal of biomedical materials research. Part A.